Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2 Positive Breast Cancer
Interventions: DRUG: Copanlisib|DRUG: Trastuzumab
Sponsor: Cancer Trials Ireland